Tumor Markers in Prostrate Cancer | p. 1 |
Biochemical Markers of Bone Remodelling for Multiple Myeloma | p. 3 |
Expression of Hepatoma-Derived Growth Factor in Thoracic Malignancy: Non-Small-Cell Lung Cancer, Malignant Pleural Mesothelioma and Thymoma | p. 33 |
Minichromosome Maintenance (MCM) Proteins as Tumor Markers: The Detection of MCM Proteins as Markers of Aberrant S-Phase Entry in Cervical Neoplasia | p. 47 |
Advances in Tumour Biomarker Discovery for Screening Gynaecological Malignancy: CA125 and Beyond | p. 63 |
Tumor Markers in Ovarian Neoplasia | p. 81 |
Biological Markers in Mammary Phyllodes Tumors | p. 93 |
Significance and Prognostic Value of Estradiol Modulating Enzymes in Breast Cancer | p. 111 |
Current and Emerging Biomarkers in Prostate Cancer | p. 121 |
Free to Total PSa Ratio Is Not Clinically Useful as an Independent Determinant of Prostate Biopsy | p. 135 |
Title Cancer-Testis Antigens as Biomarkers for the Diagnosis and Treatment of Hepatocellular Carcinoma: Usefulness and Validation in the Light of Cancer Complexity | p. 143 |
Urine Pregnancy Test as a Tumor Marker in Male Patients | p. 159 |
Epidermal Growth Factor-Like Motifs in Proteins Associated with Embryonic Development and Tumor Growth: Possible Markers for Common Functions | p. 163 |
Specific Gene Methylation as a Gastrointestinal Tumor Marker | p. 177 |
Potential Tumor Marker for Cholangiocarcinoma | p. 185 |
Alpha Fetoprotein as a Tumor Marker for Hepatoma in Populations with High Incidence of Viral Hepatitis | p. 193 |
Tumor Biomarkers for Early Detection of Hepatocellular Carcinoma | p. 197 |
Galectin-3: An Useful Tumor Marker in Thyroid and Colorectal Cancer | p. 221 |
Cell Population Structure and Tumor Cell Proliferative Indices in Lymphoid Neoplasms | p. 241 |
Case Studies on Aberration of Tumor Marker Test in Laboratory Medicine | p. 255 |
Impairment of the E-cadherin-Catenin-Complex Unit in Epithelial Ovarian Borderline and Malignant Tumours | p. 261 |
Tumor Biomarkers in Personalized Medicine | p. 275 |
Index | p. 283 |
Table of Contents provided by Blackwell. All Rights Reserved. |